drugset / Trial / NCT01689831

Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)

NCT01689831

Phase 2 Unknown 168 enrolled JHP Pharmaceuticals LLC Syneos Health · collab
RandomizedParallel-groupDouble-blindDiagnostic

Summary

Dose comparison study of tuberculin purified protein derivative (PPD)Aplisol with the standard tuberculin purified derivative (PPD-S2).

Timeline

Start
2012-05
Primary completion
2012-10
Completion
2012-12

Drugs

EvaluationDrugModalityDoseRoute
Subject PPD-S2 Unknown
Subject tuberculin Diagnostic / imaging agent

Indications